Efficacy, safety and pharmacokinetics of subcutaneous azacitidine in Chinese patients with higher risk myelodysplastic syndromes: Results from a multicenter, single‐arm, open‐label phase 2 study
Xin Du; Yue‐Yun Lai; Zhijian Xiao; Ting Liu; Yu Hu; Aining Sun; Xiao Li; Zhi‐Xiang Shen; Jie Jin; Li Yu; Eric Laille; Qian Dong; Stephen Songer; C.L. Beach
Author Information: Department of Hematology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.